4.7 Article

Transition and identification of pathological states in p53 dynamics for therapeutic intervention

期刊

SCIENTIFIC REPORTS
卷 11, 期 1, 页码 -

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41598-021-82054-1

关键词

-

资金

  1. University Grants Commission of India, New Delhi, India [21/06/2015(i)EU-V]
  2. Department of Health and Research, Ministry of Health and Family Welfare, Government of India [3146887, R.12014/01/2018-HR]
  3. JC Bose Fellowship, Department of Science and Technology, India [SR/S2/JCB-05/2008]
  4. UPE-II [101]

向作者/读者索取更多资源

In the study, it was found that the p53 regulatory network exhibits four distinct dynamical states, including active, apoptotic, pre-malignant, and cancer states, depending on the nature and level of the external stress signal. Transitions between these states are unidirectional and irreversible, with the system moving to an irreversible cancerous state under significantly large stress.
We study a minimal model of the stress-driven p53 regulatory network that includes competition between active and mutant forms of the tumor-suppressor gene p53. Depending on the nature and level of the external stress signal, four distinct dynamical states of p53 are observed. These states can be distinguished by different dynamical properties which associate to active, apoptotic, pre-malignant and cancer states. Transitions between any two states, active, apoptotic, and cancer, are found to be unidirectional and irreversible if the stress signal is either oscillatory or constant. When the signal decays exponentially, the apoptotic state vanishes, and for low stress the pre-malignant state is bounded by two critical points, allowing the system to transition reversibly from the active to the pre-malignant state. For significantly large stress, the range of the pre-malignant state expands, and the system moves to irreversible cancerous state, which is a stable attractor. This suggests that identification of the pre-malignant state may be important both for therapeutic intervention as well as for drug delivery.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据